RGC-32 as a potential biomarker of relapse and response to...

Experimental and Molecular Pathology 2015 / 12 Vol. 99; Iss. 3

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
99
Language:
english
Journal:
Experimental and Molecular Pathology
DOI:
10.1016/j.yexmp.2015.09.007
Date:
December, 2015
File:
PDF, 1.95 MB
english, 2015
Conversion to is in progress
Conversion to is failed